Clarithromycin, Tetracycline, and Bismuth: A New Non‐Metronidazole Therapy for Helicobacter pylori Infection

The American Journal of Gastroenterology

Volumn 89, Issue 8, 1994, Pages 1203-1205

  Al‐Assi, Mohammad T ^a   Ramirez, Francisco C ^a   Lew, Ginger M ^a   Genta, Robert M ^a   Graham, David Y ^a  

^a MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISMUTH; BISMUTH SALICYLATE; CLARITHROMYCIN; METRONIDAZOLE; RANITIDINE; TETRACYCLINE DERIVATIVE;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; BACTERICIDAL ACTIVITY; CLINICAL ARTICLE; DIARRHEA; DOSE RESPONSE; DRUG EFFICACY; DRUG MIXTURE; DRUG RESISTANCE; HEADACHE; HELICOBACTER PYLORI; HUMAN; MALE; NIGHTMARE; ORAL DRUG ADMINISTRATION; PEPTIC ULCER; PRIORITY JOURNAL; ULCER HEALING;

ADULT; AGED; BISMUTH; CLARITHROMYCIN; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMAN; MALE; MIDDLE AGE; ORGANOMETALLIC COMPOUNDS; PEPTIC ULCER; RANITIDINE; SALICYLATES; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; TETRACYCLINE; TIME FACTORS;

EID: 0028074524     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.1994.tb10276.x     Document Type: Article

References (44)

1. Drug therapy for Helicobacter pylori infection: Problems and pitfalls
2. Helicobacter pylori
3. The who's and when's of therapy for Helicobacter pylori
4. European Study Group on Antibiotic Susceptibility of Helicobacter pylori
5. Helicobacter pylori and metro‐nidazole resistance
6. Adjuvant antibiotic therapy in duodenal ulcers treated with colloidal bismuth subci‐trate
7. Metronidazole resistance in Helicobacter pylori
8. Metroni‐dazole‐resistant Helicobacter pylori
9. Helicobacter pylori infection treated with a tripotassium dicitrato bismuthate and metronida‐zole combination
10. Susceptibility of Campylobacter pylori to macrolides and fluoroquinolones
11. The susceptibility of Campylobacter pylori to antiulcer agents and antibiotics
12. Clarithromycin for the eradication of Helicobacter pylori
13. Clarithromycin as monotherapy for eradication of Helicobacter pylori: A randomized, double‐blind trial
14. Clarithromycin and omeprazole for Helicobacter pylori
15. Detection of Helicobacter pylori in dental plaque by reverse transcription‐polym‐erase chain reaction
16. Treatment of peptic ulcers caused by Helicobacter pylori
17. Treatment strategies for Helicobacter pylori infection
18. A non‐metronidazole triple therapy for eradication of Helicobacter pylori infection‐ tetracycline, amoxicillin, bismuth
19. Clinicopathological assessment of gastric biopsy samples of patients with Helicobacter pylori infection: Metronidazole resistance and compliance problems in the United Arab Emirates
20. Experience with triple anti‐Helicobacter pylori eradication therapy: Side effects and the importance of testing the pre‐treatment bacterial isolate for met‐ronidazole resistance
21. Eradicating Helicobacter pylori in patients with duodenal ulcer
22. Susceptibility of Helicobacter pylori to metronidazole
23. Metronidazole resistance among Heli‐cobacter pylori strains in Malaysia
24. Metronidazole‐resistant Helicobacter pylori in a developing country
25. Role of metronidazole resistance in therapy of Helicobacter pylori infections
26. Drug resistance of Helicobacter pylori: Memorandum from a meeting at the Sixth International Workshop on Campylobacter, Helicobacter, and Related Organisms
27. Prevalence of metronidazole‐resistant Helicobacter pylori in dyspeptic patients
28. Effect of varying pH on the susceptibility of Campylobacter pylori to antimicrobial agents
29. Bacteriological and pharmaceutical basis for the treatment of Helicobacter pylori infection
30. Effect of pH variation on the susceptibility of Helicobacter pylori to three macrolide antimicrobial agents and temafloxacin
31. Ciprofloxacin‐omepra‐zole combination therapy for eradication of Helicobacter pylori
32. Effect of omeprazole on H. pylori after two weeks of treatment
33. Effects of combinations of therapy with omeprazole and an antibiotic on Helicobacter pylori and duodenal ulcer disease
34. Short‐term therapy with high dosage omeprazole and amoxicillin for Helicobacter pylori eradication
35. Omeprazole plus amoxicillin: Efficacy of various treatment regimens to eradicate Helicobacter pylori
36. Short report: Omeprazole plus antibiotic combinations for the eradication of metro‐nidazole‐resistant Helicobacter pylori
37. Long‐term follow‐up after eradication of Helicobacter pylori with a combination of omeprazole and amoxycillin
38. Hp and pH: Implications for the eradication of Helicobacter pylori
39. Helicobacter pylori eradication: Efficacy and side effect profile of a combination of omeprazole, amoxycillin and metronidazole compared with four alternative regimens
40. Short report: Treatment of Helicobacter pylori‐associated duodenal ulcer with omeprazole plus antibiotics
41. Short report: High‐dose omeprazole and amoxycillin in the treatment of Helicobacter pylori‐associated duodenal ulcer
42. Omeprazole‐tetracycline combinations are inadequate as therapy for Helicobacter pylori infection
43. Effect of omeprazole on duodenal ulcer‐associated antral gastritis and Helicobacter pylori
44. Short report: The effect of omeprazole on Helicobacter pylori and associated gastritis